Cyabra CEO buys 53,650 shares and warrants

Rhea-AI Filing Summary

CYABRA, INC. Chief Executive Officer Dan Brahmy purchased 53,650 shares of Common Stock from the company on July 10, 2026, in a private placement at $0.435 per share, bringing his direct holdings to 853,052 common shares. He also bought Series A and Series B warrants, each covering 53,650 Common Stock shares at $0.45 and $0.50 per underlying share, respectively; both warrant series become exercisable upon receipt of requisite stockholder approval, with the Series B Warrants expiring 12 months and the Series A Warrants five years after their initial exercise dates.

Filing Explained

Existing holders face conditional dilution from two warrant packages, each for up to 53,650 shares, if approval is received and the warrants are exercised.

The July 13 Form 4 reports that Cyabra’s CEO acquired 53,650 CYAB common shares on July 10, 2026, at $0.435 per share in the issuer’s private placement.

It also records purchases of Series B warrants for up to 53,650 underlying common shares and Series A warrants for up to 53,650 underlying common shares; both become exercisable only upon requisite stockholder approval. If those warrants are later exercised, issuing the underlying shares would increase total shares and reduce existing holders’ percentage ownership, subject to any offsetting changes.

Form 4 is the insider-transaction report, and its table uses code P, which the supplied code reference defines as an open-market purchase. The explanation identifies the share and warrant purchases as transactions in the Private Placement, a sale of securities to selected investors outside a public offering.

The common-share acquisition is complete as reported, while the warrant-related share issuance remains conditional on stockholder approval and later exercise. The key milestones are receipt of the requisite stockholder approval and the stated expiration periods: 12 months after initial exercise for the Series B warrants and five years after initial exercise for the Series A warrants.

Insider Trade Summary

Net Buyer: 160,950 shares

Net Buy 3 txns

Insider Brahmy Dan

Role Chief Executive Officer

Bought 160,950 shs ($74K)

Type	Security	Shares	Price	Value
Purchase	Common Stock Warrants (right to buy) F2, F3, F4	53,650	$0.45	$24K
Purchase	Common Stock Warrants (right to buy) F5, F6, F7	53,650	$0.50	$27K
Purchase	Common Stock F1	53,650	$0.435	$23K

Holdings After Transaction: Common Stock Warrants (right to buy) — 245,242 contracts (Direct); Common Stock — 853,052 shares (Direct)

Footnotes (7)

1. F1. On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.
2. F2. The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.
3. F3. The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.
4. F4. The Series B Warrants expire twelve (12) months following the initial exercise date.
5. F5. The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.
6. F6. The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.
7. F7. The Series A Warrants expire five (5) years following the initial exercise date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 05:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brahmy Dan

(Last) (First) (Middle)

C/O CYABRA, INC.

13 GERSHON SHATZ

(Street)

TEL AVIV 6997543

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CYABRA, INC. [ CYAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		P		53,650(1)	A	$0.435	853,052	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Warrants (right to buy)(2)	$0.45	07/10/2026		P		53,650		(3)	(4)	Common Stock	53,650	$0.45	95,796	D
Common Stock Warrants (right to buy)(5)	$0.5	07/10/2026		P		53,650		(6)	(7)	Common Stock	53,650	$0.5	149,446	D

Explanation of Responses:

1. On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.

2. The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement.

3. The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval.

4. The Series B Warrants expire twelve (12) months following the initial exercise date.

5. The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement.

6. The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval.

7. The Series A Warrants expire five (5) years following the initial exercise date.

	/s/ Dan Brahmy	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)